Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Bone marrow histomorphology and JAK2 mutation status in essential thrombocythemia.

APMIS : acta pathologica, microbiologica, et immunologica Scandinavica - 1 Nov 2007

Stauffer Larsen Thomas, Hasselbalch Hans Carl, Pallisgaard Niels, Møller Michael Boe

Abstract excerpt

A retrospective study of 38 essential thrombocythemia (ET) patients was conducted, reviewing bone marrow biopsies according to WHO criteria using a semiquantitative scoring system. Four patients did not fulfil the WHO criteria for a myeloproliferative disorder and one biopsy was insufficient for evaluation. 14 patients were reclassified as having prefibrotic idiopathic myelofibrosis (IMF), whilst the ET diagnosis...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Erythropoiesis
Share to Fibrosis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Granulocytes

Share to Hemoglobins

Share to Megakaryocytes

Share to Platelet Count

Share to Stromal Cells

Share to Thrombocythemia, Essential

Source

Identifiers

PMID: 18092959
DOI: 10.1111/j.1600-0643.2007.00807.x

Genes

JAK2

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Bone marrow histomorphology and JAK2 mutation status in essential thrombocythemia.PMID 18092959Read ↗

Comparison of clinicopathologic findings according to JAK2 V617F mutation in patients with essential thrombocythemia.Semantic proximity Read ↗

Rationale for revision and proposed changes of the WHO diagnostic criteria for polycythemia vera, essential thrombocythemia and primary myelofibrosis.Semantic proximity Read ↗

[Essential thrombocythemia. Contribution of the V617F JAK2 mutation to the pathophysiology, diagnosis and outcome].Semantic proximity Read ↗

Comparison of JAK2V617F -positive essential thrombocythaemia and early primary myelofibrosis: The impact of mutation burden and histology.Semantic proximity Read ↗

Essential thrombocythemia vs. early/prefibrotic myelofibrosis: why does it matter.Semantic proximity Read ↗

JAK2(V617F) allele burden discriminates essential thrombocythemia from a subset of prefibrotic-stage primary myelofibrosis.Semantic proximity Read ↗

Myeloproliferative neoplasms: Morphology and clinical practiceSemantic proximity Read ↗

Triple-Negative Essential Thrombocythemia: Clinical-Pathological and Molecular Features. A Single-Center Cohort StudySemantic proximity Read ↗

Impact of JAK2V617F Mutational Status on Phenotypic Features in Essential Thrombocythemia and Primary Myelofibrosis.Semantic proximity Read ↗

[Classification and diagnosis of essential thrombocythemia].Semantic proximity Read ↗

The JAK2 V617F allele burden in essential thrombocythemia, polycythemia vera and primary myelofibrosis--impact on disease phenotype.Semantic proximity Read ↗

The relevance of a low JAK2V617F allele burden in clinical practice: a monocentric study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.